Skip to content

Erector spinae plane (ESP) block versus intercostal nerve blocks (ICNB) in uniportal videoscopic assisted thoracic surgery (VATS): A multicenter double-blind, prospective, randomized controlled trial.

Erector spinae plane (ESP) block versus intercostal nerve blocks (ICNB) in uniportal videoscopic assisted thoracic surgery (VATS): A multicenter double-blind, prospective, randomized controlled trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2021-006201-29-BE
Enrollment
100
Registered
2022-02-17
Start date
2022-04-28
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain treatment after uniportal videoscopic assisted thoracic surgery (VATS). MedDRA version: 21.1 Level: LLT Classification code 10036236 Term: Postoperative pain relief System Organ Class: 100000004865

Interventions

Trade Name: Naropin Pharmaceutical Form: Solution for injection INN or Proposed INN: Naropin CAS Number: 132112-35-7 Other descriptive name: ROPIVACAINE HYDROCHLORIDE MONOHYDRATE Concentration unit: %

Sponsors

University Hospitals Leuven
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - 18-80 years of age - Body Mass Index (BMI) = 40 kg/m2 - Patient is able to give informed consent - Patient understands the use of morphine PCIA - Patient is scheduled for elective uVATS - ASA I-IV Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 40

Exclusion criteria

Exclusion criteria: - Refusal to participate in the trial - Inability to operate a PCIA system - Chronic opioid use, or chronic pain patient - Presence of contra-indications for study medication (local anesthetic allergy)

Design outcomes

Primary

MeasureTime frame
Main Objective: To compare the efficacy of the erector spinae block with the intercostal nerve block.;Secondary Objective: not applicable;Primary end point(s): Cumulative 12-hour morphine consumption post-surgery. ;Timepoint(s) of evaluation of this end point: 12 hours after start of PCIA

Secondary

MeasureTime frame
Secondary end point(s): - Cumulative 24-hour morphine consumption post-surgery (=key secondary endpoint). - Pain intensity as assessed with the numerical rating scale (NRS) for pain - Requested dosage of morphine, administered via patient-controlled intravenous analgesia (PCIA) - Need for and dose of rescue analgesia - Incidence of postoperative surgical complications as assessed with the Clavien-Dindo Classification for complications after VATS - Day of discharge - Time to be fit for discharge as defined by reaching all the following criteria: o Oral pain medication only o Independent walking o Bowel movement o Time to first flatus (TFF) o Time to first stool (TFS) o Full oral diet o Hemodynamically (90% of baseline BP, HR in 90% or normal range) and respiratory stable (no need for extra oxygen) o No drains or urinary catheters ;Timepoint(s) of evaluation of this end point: Pain scores will be monitored every 15min after arrival in the PACU until the first 2H postoperatively. Every other endpoint will be evaluated daily until patient discharge

Countries

Belgium

Contacts

Public ContactResearch anesthesie

University Hopitals Leuven

steve.coppens@uzleuven.be+3216344270

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026